Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity (Q38022425)
Jump to navigation
Jump to search
scientific article published on September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity |
scientific article published on September 2012 |
Statements
Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity (English)
Peter J McLaughlin
1 reference
1 September 2012